| |
|
|
|
|
|
|
|||
|
Blood, 25 June 2009, Vol. 113, No. 26, pp. 6619-6628. Prepublished online as a Blood First Edition Paper on April 30, 2009; DOI 10.1182/blood-2009-01-199588.
Submitted January 15, 2009
Department Immunology, University College London, London, United Kingdom * Corresponding author; email: s.henson{at}ucl.ac.uk.
Highly differentiated CD8+CD28-CD27- T cells have short telomeres, defective telomerase activity and reduced capacity for proliferation indicating that they are close to replicative senescence. In addition these cells express increased levels of the senescence-associated inhibitory receptor KLRG1 and have poor capacity for IL-2 synthesis and defective Akt(ser473) phosphorylation after activation. It is not known whether signaling via KLRG1 contributes to any of the attenuated differentiation-related functional changes in CD8+ T cells. To address this we blocked KLRG1 signaling during TCR activation using antibodies against its major ligand, E-cadherin. This resulted in a significant enhancement of Akt(ser473) phosphorylation and TCR-induced proliferative activity of CD8+CD28-CD27- T cells. Furthermore, the increase of proliferation was directly linked to the Akt mediated induction of cyclin D and E and reduction in the cyclin inhibitor p27 expression. In contrast the reduced telomerase activity in highly differentiated CD8+CD28-CD27- T cells was not altered by KLRG1 blockade indicating the involvement of other mechanisms. This is the first demonstration of a functional role for KLRG1 in primary human CD8+ T cells and highlights that certain functional defects that arise during progressive T cell differentiation towards replicative senescence are maintained actively by inhibitory receptor signaling.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||